GP 127 Pill - white round, 13mm
Pill with imprint GP 127 is White, Round and has been identified as Metformin Hydrochloride 850 mg. It is supplied by Sandoz Pharmaceuticals Inc.
Metformin is used in the treatment of Diabetes, Type 2 and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Metformin 850 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GP 127
Metformin Hydrochloride
- Imprint
- GP 127
- Strength
- 850 mg
- Color
- White
- Size
- 13.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Non-sulfonylureas
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sandoz Pharmaceuticals Inc.
- Inactive Ingredients
-
silicon dioxide,
hypromelloses,
magnesium stearate,
polyethylene glycol,
polysorbate 80,
povidone,
sodium starch glycolate type A potato,
corn starch,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00781-5051 (Discontinued) | Sandoz Inc. |
| 00904-5850 (Discontinued) | Major Pharmaceuticals |
More about metformin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (650)
- Drug images
- Latest FDA alerts (18)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: non-sulfonylureas
- Breastfeeding
Patient resources
- Metformin drug information
- Metformin Extended-Release Suspension
- Metformin Extended-Release Tablets
- Metformin Tablets
- Metformin Oral Solution
Other brands
Glucophage, Glumetza, Glucophage XR, Fortamet, ... +2 more
Professional resources
- MetFORMIN monograph
- Metformin (FDA)
- Metformin Aerosol (FDA)
- Metformin Extended Release Tablet (FDA)
- Metformin Extended Release Tablets (FDA)
- Metformin Oral Solution (FDA)
Other brands
Glucophage, Glumetza, Glucophage XR, Fortamet, Riomet
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
